Business Description
CXI Healthcare Technology Group Ltd
ISIN : KYG2114A1094
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 852.91 | |||||
Equity-to-Asset | 0.99 | |||||
Interest Coverage | 3729.83 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 6.54 | |||||
Beneish M-Score | -2.26 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -33.8 | |||||
3-Year EBITDA Growth Rate | -0.2 | |||||
3-Year EPS without NRI Growth Rate | 26.6 | |||||
3-Year Book Growth Rate | -19.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.08 | |||||
9-Day RSI | 32.18 | |||||
14-Day RSI | 35.27 | |||||
6-1 Month Momentum % | -30.43 | |||||
12-1 Month Momentum % | -28.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 73.03 | |||||
Quick Ratio | 72.99 | |||||
Cash Ratio | 62.42 | |||||
Days Inventory | 1.2 | |||||
Days Sales Outstanding | 97.99 | |||||
Days Payable | 16.28 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -35.2 | |||||
Shareholder Yield % | 1.04 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 43.06 | |||||
Operating Margin % | 27.19 | |||||
Net Margin % | 42.34 | |||||
FCF Margin % | 63.13 | |||||
ROE % | 6.64 | |||||
ROA % | 6.6 | |||||
ROIC % | 6.01 | |||||
ROC (Joel Greenblatt) % | 10.29 | |||||
ROCE % | 6.63 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 0.61 | |||||
PE Ratio without NRI | 0.72 | |||||
PS Ratio | 0.27 | |||||
PB Ratio | 0.04 | |||||
Price-to-Tangible-Book | 0.04 | |||||
Price-to-Free-Cash-Flow | 0.37 | |||||
Price-to-Operating-Cash-Flow | 0.37 | |||||
EV-to-EBIT | -4.7 | |||||
EV-to-EBITDA | -2.56 | |||||
EV-to-Revenue | -1.98 | |||||
EV-to-FCF | -3.14 | |||||
Price-to-Median-PS-Value | 0.68 | |||||
Price-to-Graham-Number | 0.04 | |||||
Price-to-Net-Current-Asset-Value | 0.11 | |||||
Price-to-Net-Cash | 0.13 | |||||
Earnings Yield (Greenblatt) % | -21.27 | |||||
FCF Yield % | 199.01 | |||||
Forward Rate of Return (Yacktman) % | 904.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
CXI Healthcare Technology Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 69,167.292 | ||
EPS (TTM) (â‚©) | 119 | ||
Beta | 0.13 | ||
Volatility % | 25.38 | ||
14-Day RSI | 35.27 | ||
14-Day ATR (â‚©) | 3.379838 | ||
20-Day SMA (â‚©) | 76.3 | ||
12-1 Month Momentum % | -28.57 | ||
52-Week Range (â‚©) | 70 - 154 | ||
Shares Outstanding (Mil) | 300.58 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
CXI Healthcare Technology Group Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
CXI Healthcare Technology Group Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
CXI Healthcare Technology Group Ltd Frequently Asked Questions
What is CXI Healthcare Technology Group Ltd(XKRX:900120)'s stock price today?
When is next earnings date of CXI Healthcare Technology Group Ltd(XKRX:900120)?
Does CXI Healthcare Technology Group Ltd(XKRX:900120) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |